Research ArticleArticle
Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality
Karina Raimundo, Joshua J. Solomon, Amy L. Olson, Amanda M. Kong, Ashley L. Cole, Aryeh Fischer and Jeffrey J. Swigris
The Journal of Rheumatology November 2018, jrheum.171315; DOI: https://doi.org/10.3899/jrheum.171315
Karina Raimundo
From Genentech Inc., South San Francisco, California; National Jewish Health, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; University of Colorado School of Medicine, Denver, Colorado, USA. This analysis was funded by Genentech Inc. and F. Hoffmann-La Roche Ltd. K. Raimundo, MS, Genentech Inc.; J.J. Solomon, MD, National Jewish Health; A.L. Olson, MD, National Jewish Health; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; A.L. Cole, MPH, Truven Health Analytics, an IBM Company; A. Fischer, MD, University of Colorado School of Medicine; J.J. Swigris, DO, MS, National Jewish Health. Address correspondence to K. Raimundo, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 8, 2018.
Joshua J. Solomon
From Genentech Inc., South San Francisco, California; National Jewish Health, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; University of Colorado School of Medicine, Denver, Colorado, USA. This analysis was funded by Genentech Inc. and F. Hoffmann-La Roche Ltd. K. Raimundo, MS, Genentech Inc.; J.J. Solomon, MD, National Jewish Health; A.L. Olson, MD, National Jewish Health; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; A.L. Cole, MPH, Truven Health Analytics, an IBM Company; A. Fischer, MD, University of Colorado School of Medicine; J.J. Swigris, DO, MS, National Jewish Health. Address correspondence to K. Raimundo, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 8, 2018.
Amy L. Olson
From Genentech Inc., South San Francisco, California; National Jewish Health, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; University of Colorado School of Medicine, Denver, Colorado, USA. This analysis was funded by Genentech Inc. and F. Hoffmann-La Roche Ltd. K. Raimundo, MS, Genentech Inc.; J.J. Solomon, MD, National Jewish Health; A.L. Olson, MD, National Jewish Health; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; A.L. Cole, MPH, Truven Health Analytics, an IBM Company; A. Fischer, MD, University of Colorado School of Medicine; J.J. Swigris, DO, MS, National Jewish Health. Address correspondence to K. Raimundo, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 8, 2018.
Amanda M. Kong
From Genentech Inc., South San Francisco, California; National Jewish Health, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; University of Colorado School of Medicine, Denver, Colorado, USA. This analysis was funded by Genentech Inc. and F. Hoffmann-La Roche Ltd. K. Raimundo, MS, Genentech Inc.; J.J. Solomon, MD, National Jewish Health; A.L. Olson, MD, National Jewish Health; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; A.L. Cole, MPH, Truven Health Analytics, an IBM Company; A. Fischer, MD, University of Colorado School of Medicine; J.J. Swigris, DO, MS, National Jewish Health. Address correspondence to K. Raimundo, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 8, 2018.
Ashley L. Cole
From Genentech Inc., South San Francisco, California; National Jewish Health, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; University of Colorado School of Medicine, Denver, Colorado, USA. This analysis was funded by Genentech Inc. and F. Hoffmann-La Roche Ltd. K. Raimundo, MS, Genentech Inc.; J.J. Solomon, MD, National Jewish Health; A.L. Olson, MD, National Jewish Health; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; A.L. Cole, MPH, Truven Health Analytics, an IBM Company; A. Fischer, MD, University of Colorado School of Medicine; J.J. Swigris, DO, MS, National Jewish Health. Address correspondence to K. Raimundo, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 8, 2018.
Aryeh Fischer
From Genentech Inc., South San Francisco, California; National Jewish Health, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; University of Colorado School of Medicine, Denver, Colorado, USA. This analysis was funded by Genentech Inc. and F. Hoffmann-La Roche Ltd. K. Raimundo, MS, Genentech Inc.; J.J. Solomon, MD, National Jewish Health; A.L. Olson, MD, National Jewish Health; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; A.L. Cole, MPH, Truven Health Analytics, an IBM Company; A. Fischer, MD, University of Colorado School of Medicine; J.J. Swigris, DO, MS, National Jewish Health. Address correspondence to K. Raimundo, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 8, 2018.
Jeffrey J. Swigris
From Genentech Inc., South San Francisco, California; National Jewish Health, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; University of Colorado School of Medicine, Denver, Colorado, USA. This analysis was funded by Genentech Inc. and F. Hoffmann-La Roche Ltd. K. Raimundo, MS, Genentech Inc.; J.J. Solomon, MD, National Jewish Health; A.L. Olson, MD, National Jewish Health; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; A.L. Cole, MPH, Truven Health Analytics, an IBM Company; A. Fischer, MD, University of Colorado School of Medicine; J.J. Swigris, DO, MS, National Jewish Health. Address correspondence to K. Raimundo, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 8, 2018.
Article Figures & Data
Additional Files
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality
Karina Raimundo, Joshua J. Solomon, Amy L. Olson, Amanda M. Kong, Ashley L. Cole, Aryeh Fischer, Jeffrey J. Swigris
The Journal of Rheumatology Nov 2018, jrheum.171315; DOI: 10.3899/jrheum.171315
Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality
Karina Raimundo, Joshua J. Solomon, Amy L. Olson, Amanda M. Kong, Ashley L. Cole, Aryeh Fischer, Jeffrey J. Swigris
The Journal of Rheumatology Nov 2018, jrheum.171315; DOI: 10.3899/jrheum.171315